Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma
Year: 2016
Type: article
Source: Europe PMC (PubMed Central)
Author: Raedler, Lisa A.
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6996335877
